Mitralign

company

About

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

  • 51 - 100

Details

Last Funding Type
Series D
Last Funding Money Raised
$35M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

Mitralign is a venture backed privately held company located in a suburb of Boston, MA. The company is developing an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system emulates surgical annuloplasty as it delivers a series of surgical implants directly into the mitral annulus by means of a catheter. The implants are cinched together, thus reducing the size of the mitral valve annulus and the valve opening.

Mitralign is funded by top tier venture capitalists and has two major cardiovascular device companies as investors.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$82.20M
Mitralign has raised a total of $82.20M in funding over 2 rounds. Their latest funding was raised on May 16, 2012 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 16, 2012 Series D $35M 1 Detail
Dec 31, 2007 Series C $24M 1 Medtronic Detail
Jun 30, 2006 Series B $13M 1 Detail
Jun 8, 2005 Series Unknown $6.70M 1 Detail
May 10, 2004 Series A $3.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Mitralign is funded by 2 investors. Medtronic and Accelerated Technologies Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Medtronic Series D
Accelerated Technologies Partners Series B